Sei Muraoka

Tokyo, 1438541, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Efficacy of romosozumab as sequential therapy for bisphosphonates in glucocorticoid-induced osteoporosis.

Efficacy of romosozumab as sequential therapy for bisphosphonates in glucocorticoid-induced osteoporosis.

Journal: JBMR plus
Published: March 08, 2026

Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial.

Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: January 27, 2026

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Journal: Annals of the rheumatic diseases
Published: October 27, 2025

Anti-SRP antibody-positive polymyositis complicated by neuromyelitis optica spectrum disorder: a case report and literature review.

Anti-SRP antibody-positive polymyositis complicated by neuromyelitis optica spectrum disorder: a case report and literature review.

Journal: Modern rheumatology case reports
Published: September 29, 2025

Effectiveness of Daily Teriparatide in Managing Glucocorticoid-Induced Osteoporosis in Rheumatic Disease Patients After Switching From Bisphosphonate Therapy.

Effectiveness of Daily Teriparatide in Managing Glucocorticoid-Induced Osteoporosis in Rheumatic Disease Patients After Switching From Bisphosphonate Therapy.

Journal: Cureus
Published: April 17, 2025

Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy.

Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy.

Journal: The Journal of clinical endocrinology and metabolism
Published: August 01, 2024

Associations of gut microbiota with disease development, disease activity, and therapeutic effects in patients with systemic lupus erythematosus.

Associations of gut microbiota with disease development, disease activity, and therapeutic effects in patients with systemic lupus erythematosus.

Journal: Scientific reports
Published: July 31, 2024

Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis.

Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 19, 2024

Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study.

Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study.

Journal: Arthritis research & therapy
Published: December 02, 2023

Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer Cells.

Activation of Cytotoxic Lymphocytes Through CD6 Enhances Killing of Cancer Cells.

Journal: Research square
Published: October 27, 2023

Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells.

Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells.

Journal: Cancer immunology, immunotherapy : CII
Published: October 02, 2023

Relationship Between the Lipidome Profile and Disease Activity in Patients with Rheumatoid Arthritis.

Relationship Between the Lipidome Profile and Disease Activity in Patients with Rheumatoid Arthritis.

Journal: Inflammation
Published: September 08, 2023
Showing 1-12 of 26

Last Updated: 09/26/2026